Impact Of The 2022 Bronchodilator Responsiveness Criteria On Study Eligibility and Treatment Response To Inhaled Triple Therapy (BDP/FF/GB) In Moderate-To-Severe Asthma: A Post-Hoc Analysis Of TRIMARAN & TRIGGER.
Year: 2024
Type: conference-abstract
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404100707
